| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
*
Department of Immunology and
Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Department of Biology, Case Western Reserve University, Cleveland, OH 44106; and
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106
During sensitization with dinitrofluorobenzene for contact
hypersensitivity (CHS) responses, hapten-specific CD8+ T
cells develop into IFN-
-producing cells, and CD4+ T
cells develop into IL-4/IL-5-producing cells. Administration of IL-12
during sensitization skews CD4+ T cell development to
IFN--producing cells, resulting in exaggerated CHS responses. In the
current report we tested the role of IL-12 on CD8+ T cell
development during sensitization and elicitation of CHS to
dinitrofluorobenzene. Administration of IL-12 during hapten
sensitization induced the expression of IL-12R
2 on both
CD4+ and CD8+ T cells, augmented IFN-
production by these T cell populations, and increased the magnitude and
duration of the CHS response to hapten challenge. CHS responses were
virtually identical in wild-type and IL-12 p40-/- mice.
Since engagement of CD40 on APC may stimulate IL-12 production, we also
tested the role of CD40-CD154 interactions on the development of
IFN--producing CD4+ and CD8+ T cells
following hapten sensitization. Development of IFN--producing
CD4+ T cells during hapten sensitization was absent in
wild-type mice treated with anti-CD154 mAb or in
CD154-/- mice. In contrast, the absence of CD40-CD154
signaling had little or no impact on the development of
IFN--producing CD8+ T cells. These results demonstrate
that the development of hapten-specific Th1 effector CD4+ T
cells in CHS requires both CD40-CD154 interactions and IL-12, whereas
the development of IFN--producing effector CD8+ T cells
can occur independently of these pathways.
This article has been cited by other articles:
|
|
 |
|
  P. Gurung, T. A. Kucaba, T. A. Ferguson, and T. S. Griffith Activation-Induced CD154 Expression Abrogates Tolerance Induced by Apoptotic Cells J. Immunol., November 15, 2009; 183(10): 6114 - 6123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Martin, J. C. Dudda, E. Bachtanian, A. Lembo, S. Liller, C. Durr, M. M. Heimesaat, S. Bereswill, G. Fejer, R. Vassileva, et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity J. Exp. Med., September 1, 2008; 205(9): 2151 - 2162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. He, L. Wu, H. K. Kim, H. Li, C. A. Elmets, and H. Xu CD8+ IL-17-Producing T Cells Are Important in Effector Functions for the Elicitation of Contact Hypersensitivity Responses J. Immunol., November 15, 2006; 177(10): 6852 - 6858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Riemann, K. Loser, S. Beissert, M. Fujita, A. Schwarz, T. Schwarz, and S. Grabbe IL-12 Breaks Dinitrothiocyanobenzene (DNTB)-Mediated Tolerance and Converts the Tolerogen DNTB into an Immunogen J. Immunol., November 1, 2005; 175(9): 5866 - 5874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Gorbachev and R. L. Fairchild CD40 Engagement Enhances Antigen-Presenting Langerhans Cell Priming of IFN-{gamma}-Producing CD4+ and CD8+ T Cells Independently of IL-12 J. Immunol., August 15, 2004; 173(4): 2443 - 2452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Salem, A. N. Kadima, Y. Zhou, C. L. Nguyen, M. P. Rubinstein, M. Demcheva, J. N. Vournakis, D. J. Cole, and W. E. Gillanders Paracrine Release of IL-12 Stimulates IFN-{gamma} Production and Dramatically Enhances the Antigen-Specific T Cell Response after Vaccination with a Novel Peptide-Based Cancer Vaccine J. Immunol., May 1, 2004; 172(9): 5159 - 5167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Akiba, J. Kehren, M.-T. Ducluzeau, M. Krasteva, F. Horand, D. Kaiserlian, F. Kaneko, and J.-F. Nicolas Skin Inflammation During Contact Hypersensitivity Is Mediated by Early Recruitment of CD8+ T Cytotoxic 1 Cells Inducing Keratinocyte Apoptosis J. Immunol., March 15, 2002; 168(6): 3079 - 3087. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
